Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00857727 · ClinicalTrials.gov registry record · Phase 3

Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children

A Phase 3 study of Anesthesia and Pediatrics, sponsored by St. Luke's-Roosevelt Hospital Center.

Completed
Registry status
Phase 3
Development phase
33
Enrollment target
1
Study location

NCT00857727 is a Phase 3 study of Anesthesia and Pediatrics that has completed, run by St. Luke's-Roosevelt Hospital Center. The registered enrollment target is 33 participants, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00857727, a Phase 3 study of Anesthesia and Pediatrics, has completed, sponsored by St. Luke's-Roosevelt Hospital Center.

COMPLETED
Registry status
Phase 3
Development phase
33 participants
Enrollment target
1
Study location

Study Summary

Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

Interventions

  • DRUG Saline
  • DRUG Dexmedetomidine

Study Locations (1)

New York

  • St Luke's-Roosevelt Hospital Center - New York

Trial Details

FieldValue
Enrollment Target 33 participants
Start Date 2009-08
Est. Completion 2011-12
Phase Phase 3

What the Registry Record Tells You About NCT00857727

The ClinicalTrials.gov registry entry for NCT00857727 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 109,410-participant average among 57 other Anesthesia trials with a reported enrollment target (100% lower). The listed sponsor is St. Luke's-Roosevelt Hospital Center, which has 57 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Anesthesia appearing as the primary indexed condition, and to 2 interventions - of which Saline is the first listed.

NCT00857727 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT00857727 about?

NCT00857727 is a clinical study titled "Use of Dexmedetomidine to Reduce Emergence Delirium Incident in Children". Emergence delirium (ED) from general anesthesia posts risk and harm to pediatric population undergo general anesthesia. The purpose of the study is to compare the use of dexmedetomidine versus placebo in reducing the incidence and severity of ED in a pediatric neurosurgical population.

What is the current status of trial NCT00857727?

This trial is currently completed. It is a Phase 3 study. The enrollment target is 33 participants. The study started on 2009-08. Estimated completion is 2011-12.

What conditions does trial NCT00857727 study?

This clinical trial studies the following conditions: Anesthesia, Pediatrics, Agitation.

What interventions are being tested in trial NCT00857727?

The interventions under investigation include: Saline (DRUG), Dexmedetomidine (DRUG).

Who is sponsoring clinical trial NCT00857727?

This trial is sponsored by St. Luke's-Roosevelt Hospital Center, which has 57 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00857727 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Anesthesia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.